Medtronic Hopes CMS’ Inpatient Payment Shift Will Reverse ICD Slowdown
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is banking on CMS' decision to soften proposed reimbursement cuts to turn around its struggling cardiac rhythm management business
You may also be interested in...
Medtronic Projects ICD Recovery In 2007, Double-Digit Growth Potential
Medtronic remains confident that the worldwide implantable cardioverter defibrillator market will achieve low double-digit growth over the next five years despite current headwinds facing the sector
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.